Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $15.23 M | -70.7% |
2023 | $51.99 M | -66.55% |
2022 | $0.15 B | 200.46% |
2021 | $51.74 M | -9.83% |
2020 | $57.38 M | 52.34% |
2019 | $37.66 M | 46.52% |
2018 | $25.7 M | -70.97% |
2017 | $88.54 M | 191.96% |
2016 | $30.32 M | -14.94% |
2015 | $35.65 M | 68.07% |
2014 | $21.21 M | 152.1% |
2013 | $8.41 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Novartis NVS | $18.64 M | $83.53 M | ๐จ๐ญ Switzerland |
Sanofi SNY | $21.22 M | $52.23 M | ๐ซ๐ท France |
Regeneron Pharmaceuticals REGN | $1.06 M | $0.14 B | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | $2.46 M | $33.71 M | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | $3.96 M | $4.04 M | ๐บ๐ธ USA |
OPKO Health
OPK | $40.16 M | $49.72 M | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $5.61 M | $30.31 M | ๐ฎ๐ฑ Israel |
Arrowhead Pharmaceuticals
ARWR | $3.95 M | $9.77 M | ๐บ๐ธ USA |